BioTalk with Rich Bendis Podcast Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk Vita Therapeutics CEO & Co-founder Douglas Falk chats with Rich Bendis to discuss his career, their platforms, and moving into…adminMay 16, 2022
BioTalk with Rich Bendis Podcast Special Edition BioTalk: Dave Saunders, CTO & Co-Founder of Galen Robotics Dave Saunders, CTO & Co-Founder of Galen Robotics, joins Rich Bendis before their 5/6/2022 Open House in Baltimore. (RSVP to…adminMay 4, 2022
BioTalk with Rich Bendis Podcast Maryland Commerce Secretary Mike Gill Guests on BioTalk with Rich Bendis Podcast Mike Gill, Maryland Commerce Secretary, visits BioTalk to discuss Life Sciences in the State, growing the economy, and how we…adminMay 2, 2022
BioTalk with Rich Bendis Podcast Raymond Blanchard, Associate Director of IP & Licensing with QIAGEN, visits BioTalk QIAGEN Associate Director of IP & Licensing, Raymond Blanchard, chats with Rich Bendis on BioTalk to discuss innovation, intellectual property…adminApril 25, 2022
BioTalk with Rich Bendis Podcast Darryll J. Pines, President, University of Maryland, Visits with Rich Bendis on BioTalk Darryll J. Pines, President, University of Maryland, Joins BioTalk to discuss all things relating the University to the BioHealth Capital…adminMarch 21, 2022
BioTalk with Rich Bendis Podcast Dr. Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Visits BioTalk Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Joins BioTalk to discuss his career path, loving Baltimore, and…adminMarch 14, 2022
BioTalk with Rich Bendis Podcast Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., visits the BioTalk Podcast Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., joins BioTalk to discuss his career, growth opportunities, and Canon’s…adminFebruary 28, 2022
BioTalk with Rich Bendis Podcast Maryland Tech Council CEO Marty Rosendale joins Rich Bendis on BioTalk Marty Rosendale, Chief Executive Officer of the Maryland Tech Council, joins BioTalk to discuss MTCs Programs, Accessing Capital, and Goals…adminFebruary 21, 2022
BioTalk with Rich Bendis Podcast United States Pharmacopeia CEO Ron Piervincenzi, Ph.D., returns to BioTalk Ron Piervincenzi, Ph.D., CEO of United States Pharmacopeia, sits down with host, Rich Bendis, to discuss USP’s growth since his…adminFebruary 14, 2022
BioTalk with Rich Bendis Podcast Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, visits Rich Bendis to discuss his career from NIH, to CEO of Avidea, to…adminFebruary 7, 2022